Thu, Jul 31, 2014, 6:50 AM EDT - U.S. Markets open in 2 hrs 40 mins

Recent

% | $
Click the to save as a favorite.

Trius Therapeutics, Inc. (TSRX) Message Board

sonofarailman 13 posts  |  Last Activity: May 21, 2014 6:20 PM Member since: Jul 21, 2005
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • sonofarailman by sonofarailman May 21, 2014 6:20 PM Flag

    Many people treat their pets better than their relatives. This trend is increasing and will cause this company to grow steadily with low debt. I'm a value investor and buyer for the long term here. Goal: $69, a 20% gain from here by the end of the year.

    Sentiment: Strong Buy

  • sonofarailman by sonofarailman Mar 26, 2014 6:13 PM Flag

    This stock gets the highest recommendation from Morningstar, 5 stars. Why does it trade at $1.70? " We're maintaining our fair value estimate for Lexicon at $3.50 per share. Although we have removed sales from our valuation model for LX1033 in irritable bowel syndrome, we think progress with LX4211 in renal impairment and type I diabetes warrants a higher assumed probability of approval, and we have raised the probability in our model to 50% from 30%. We think LX4211 could achieve peak sales above $2 billion. This implies a roughly 10% share of the SGLT-2 market by 2018 and a 20% share by 2022. We now think a potential partner could be waiting for data from a type I diabetes study (expected in the first quarter of 2014) before inking a deal. Therefore, we assume that Lexicon will begin to receive milestone and upfront payments from new partnerships in 2014. We still assign telotristat etiprate (LX1032) a 60% probability of approval, as the drug entered Phase III trials in 2013. We expect LX1032 to see peak sales above $300 million, and we assume that Lexicon retains full rights to this rare-disease drug. We're maintaining our fair value estimate for Lexicon at $3.50 per share. Although we have removed sales from our valuation model for LX1033 in irritable bowel syndrome, we think progress with LX4211 in renal impairment and type I diabetes warrants a higher assumed probability of approval, and we have raised the probability in our model to 50% from 30%. We think LX4211 could achieve peak sales above $2 billion. This implies a roughly 10% share of the SGLT-2 market by 2018 and a 20% share by 2022. We now think a potential partner could be waiting for data from a type I diabetes study (expected in the first quarter of 2014) before inking a deal. Therefore, we assume that Lexicon will begin to receive milestone and upfront payments from new partnerships in 2014..."

    Sentiment: Buy

  • sonofarailman by sonofarailman Mar 20, 2014 6:39 AM Flag

    Only 3 per cent of all ANDA's are approved by the FDA. This one won't be in the near future. The results will be somewhat positive, but need much more testing over years and years with much larger expensive trials. The current samples are much too small. The bull market in this stock is long in the tooth. I 'm taking my profits and going.

    Sentiment: Sell

  • sonofarailman by sonofarailman Mar 12, 2014 9:59 AM Flag

    S and P gives this firm 5 stars. The target price is $100. Revenues will pick up in Fiscal '15, beginning soon. I can't see that the missing Malaysian airliner's problems were caused by TGI. Current international tensions and demand for international travel by the growing new word-wide middle class will bolster travel, aircraft orders and TGI's components business. If the selling is now, it is almost over. The new Dallas factory will bolster efficiency. This is an $77-$80 plus value stock, with a 20% upside from here within less than a year. I'm a long term buyer here for my retirement fund. Where is the serious comment on this board?

    Sentiment: Strong Buy

  • sonofarailman by sonofarailman Jan 3, 2014 6:04 PM Flag

    Morningstar gives EXC a strong analyst report, 5 Stars for the long term and a $42 Fair Value. I'm a buyer here for the long haul with the dividend for my IRA. With E.P.A. limits on coal, nuclear is a steady pollution free power source with a strong moat. It is also O.K. with Obama's E.P.A. Taper means slow the buying while interest rates are kept low by the Fed. through 2014 at least, not raise them soon. Thanks, Citi for the gift! I think your downgrade is wrong!

    Sentiment: Strong Buy

  • sonofarailman by sonofarailman Nov 27, 2013 8:11 AM Flag

    In my opinion, short term panic equals a buying opportunity. In 5 years, almost all electronic passwords (billions of them) will be spoken (not typed) using Nuance type products for voice recognition. (Hear Vanguard Funds voice recognition rather than type a password). Hacking passwords will be over. This is your chance to get in. I'm all in at these prices for the long term. Buy-buy-buy.

    Sentiment: Strong Buy

  • My clients who are suffering from Parkinson's are hopeful and looking forward to positive results.

    Sentiment: Strong Buy

  • Would there be any future value?

  • Reply to

    Extended Tender Date

    by sonofarailman Sep 6, 2013 7:05 AM
    sonofarailman sonofarailman Sep 6, 2013 5:16 PM Flag

    Sorry. My original post said I received the call on Sept. 6th. It was a Sept. 5th robo call announcing the extension to Sept. 13th..

  • sonofarailman by sonofarailman Sep 6, 2013 7:05 AM Flag

    I have gotten a call from TSRX on Sept. 6th that the tender date has been extended to Sept. 13th What does this mean re: the tender offer?

  • sonofarailman by sonofarailman Sep 3, 2013 12:02 PM Flag

    This stock will be like TSRX, a company stock that I have that gets bought out by a larger company for large profit for investors who have faith in the product(s) being developed or being sold. I think that LF will be enormously successful at Xmas and then be bought next year by mattel or hasbro for $13 to $17 per share. A glitch in one of their many fine products doesn't mean much to me. I'm in. LF is on a one-day-sale. Ca-Ching!

    Sentiment: Strong Buy

  • Reply to

    Is now a good time to buy ?

    by berchik Aug 14, 2013 2:17 PM
    sonofarailman sonofarailman Aug 16, 2013 11:54 AM Flag

    This is my buy point. This stock will be in the 90's in 3 years or less.

    Sentiment: Buy

  • sonofarailman by sonofarailman Aug 1, 2013 11:34 AM Flag

    Doesn't this company have a history of the share price dropping on the earnings news?

    Sentiment: Sell

TSRX
13.630.00(0.00%)Sep 11 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Yelp, Inc.
NYSEWed, Jul 30, 2014 4:00 PM EDT
Whole Foods Market, Inc.
NasdaqGSWed, Jul 30, 2014 4:00 PM EDT